etidronate has been researched along with Hypogonadism in 5 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Hypogonadism: Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism).
Excerpt | Relevance | Reference |
---|---|---|
" Treatments were as follows: idiopathic osteoporosis: calcium and vitamin D supplements (N = 10) or cyclical etidronate for 2 weeks followed by calcium and vitamin D supplements for 76 days (N = 29); moderate idiopathic phosphate diabetes: calcitriol and phosphate (N = 15); idiopathic hypercalciuria: hydrochlorothiazide (N = 6); and hypogonadism: testosterone (N = 3)." | 5.09 | Management of male osteoporosis. ( Catanzariti, L; Cortet, B; Delcambre, B; Grardel, B; Marchandise, X; Vasseur, J, 2001) |
"Although osteoporosis is generally regarded as a disease of women, up to 30% of hip fractures and 20% of vertebral fractures occur in men." | 2.40 | Management of male osteoporosis: report of the UK Consensus Group. ( Boyle, IT; Compston, J; Cooper, C; Eastell, R; Fogelman, I; Francis, RM; Hosking, DJ; Purdie, DW; Ralston, S; Reeve, J; Reid, DM; Russell, RG; Stevenson, JC, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pepe, J | 1 |
Isidori, AM | 1 |
Falciano, M | 1 |
Iaiani, G | 1 |
Salotti, A | 1 |
Diacinti, D | 1 |
Del Fiacco, R | 1 |
Sbardella, E | 1 |
Cipriani, C | 1 |
Piemonte, S | 1 |
Raimo, O | 1 |
Biondi, P | 1 |
Biamonte, F | 1 |
Lenzi, A | 1 |
Minisola, S | 1 |
Ringe, JD | 1 |
Eastell, R | 1 |
Boyle, IT | 1 |
Compston, J | 1 |
Cooper, C | 1 |
Fogelman, I | 1 |
Francis, RM | 1 |
Hosking, DJ | 1 |
Purdie, DW | 1 |
Ralston, S | 1 |
Reeve, J | 1 |
Reid, DM | 1 |
Russell, RG | 1 |
Stevenson, JC | 1 |
Cortet, B | 1 |
Vasseur, J | 1 |
Grardel, B | 1 |
Catanzariti, L | 1 |
Marchandise, X | 1 |
Delcambre, B | 1 |
Libouban, H | 1 |
Moreau, MF | 1 |
Legrand, E | 1 |
Baslé, MF | 1 |
Audran, M | 1 |
Chappard, D | 1 |
2 reviews available for etidronate and Hypogonadism
Article | Year |
---|---|
[Osteoporosis in men].
Topics: Alendronate; Androgens; Calcium Channel Blockers; Diagnosis, Differential; Etidronic Acid; Fractures | 2003 |
Management of male osteoporosis: report of the UK Consensus Group.
Topics: Adult; Aged; Aged, 80 and over; Alcoholism; Diphosphonates; Etidronic Acid; Glucocorticoids; Humans; | 1998 |
1 trial available for etidronate and Hypogonadism
Article | Year |
---|---|
Management of male osteoporosis.
Topics: Absorptiometry, Photon; Bone Density; Calcitriol; Calcium; Dietary Supplements; Etidronic Acid; Femu | 2001 |
2 other studies available for etidronate and Hypogonadism
Article | Year |
---|---|
Effect of risedronate in osteoporotic HIV males, according to gonadal status: a pilot study.
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Chol | 2014 |
Comparison insight dual X-ray absorptiometry (DXA), histomorphometry, ash weight, and morphometric indices for bone evaluation in an animal model (the orchidectomized rat) of male osteoporosis.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone and Bones; Bone Density; Climacteric; Disease Mod | 2001 |